Claudia B Padula1,2, Annika Hansen2, Rachel L Hughes1,2, M Windy McNerney1,2. 1. VA Palo Alto Health Care System, Mental Illness Research, Education, and Clinical Center (MIRECC), Palo Alto, CA 94304, USA. 2. Department of Psychiatry and Behavioral Sciences, Stanford University, Stanford, CA 94305, USA.
Abstract
(1) Background: Alcohol use disorder (AUD) is associated with poor medical, psychological, and psychosocial outcomes and approximately 60% of individuals with AUD relapse six months after treatment. Craving is a core aspect of AUD and associated with high risk of relapse. One promising avenue to improve outcomes may be in understanding the relationship between COMT genotype, craving, and treatment outcomes. (2) Methods: To this end, we assessed craving, recent drinking history, and impulsivity in 70 individuals with AUD undergoing a standard course of treatment at a regional Veteran Affairs (VA) medical center. Saliva samples were collected to determine COMT genotype. In this prospective observational study, participants were followed for six months to determine who went on to relapse after treatment. (3) Results: Results revealed a significant interaction between craving and catechol-O-methyltransferse (COMT) genotype in predicting relapse. Post hoc exploratory analyses indicated that Met/Met homozygotes reported the highest levels of craving, and craving was associated with recent drinking history. Among Val/Val homozygotes, who had higher rates of relapse, craving was associated with impulsivity. (4) Conclusions: These associations highlight that specific profiles of psychological and biological factors may be important in understanding which individuals are at highest risk of relapse following treatment. Future studies that build on these findings are warranted.
(1) Background: Alcohol use disorder (AUD) is associated with poor medical, psychological, and psychosocial outcomes and approximately 60% of individuals with AUD relapse six months after treatment. Craving is a core aspect of AUD and associated with high risk of relapse. One promising avenue to improve outcomes may be in understanding the relationship between COMT genotype, craving, and treatment outcomes. (2) Methods: To this end, we assessed craving, recent drinking history, and impulsivity in 70 individuals with AUD undergoing a standard course of treatment at a regional Veteran Affairs (VA) medical center. Saliva samples were collected to determine COMT genotype. In this prospective observational study, participants were followed for six months to determine who went on to relapse after treatment. (3) Results: Results revealed a significant interaction between craving and catechol-O-methyltransferse (COMT) genotype in predicting relapse. Post hoc exploratory analyses indicated that Met/Met homozygotes reported the highest levels of craving, and craving was associated with recent drinking history. Among Val/Val homozygotes, who had higher rates of relapse, craving was associated with impulsivity. (4) Conclusions: These associations highlight that specific profiles of psychological and biological factors may be important in understanding which individuals are at highest risk of relapse following treatment. Future studies that build on these findings are warranted.
Authors: Andreas Heinz; Thomas Siessmeier; Jana Wrase; Hans Georg Buchholz; Gerhard Gründer; Yoshitaka Kumakura; Paul Cumming; Mathias Schreckenberger; Michael N Smolka; Frank Rösch; Karl Mann; Peter Bartenstein Journal: Am J Psychiatry Date: 2005-08 Impact factor: 18.112
Authors: D V Sheehan; Y Lecrubier; K H Sheehan; P Amorim; J Janavs; E Weiller; T Hergueta; R Baker; G C Dunbar Journal: J Clin Psychiatry Date: 1998 Impact factor: 4.384
Authors: Tatiana Foroud; Leah Flury Wetherill; Danielle M Dick; Victor Hesselbrock; John I Nurnberger; John Kramer; Jay Tischfield; Marc Schuckit; Laura J Bierut; Xiaoling Xuei; Howard J Edenberg Journal: Alcohol Clin Exp Res Date: 2007-09-11 Impact factor: 3.455
Authors: Susan Spillane; Meredith S Shiels; Ana F Best; Emily A Haozous; Diana R Withrow; Yingxi Chen; Amy Berrington de González; Neal D Freedman Journal: JAMA Netw Open Date: 2020-02-05